Lisa Nibauer
Plus aucun poste en cours
Profil
Lisa Nibauer worked as the President-Diagnostics at OraSure Technologies, Inc. from 2021 to 2022.
Prior to that, she was the VP-Global Medication Delivery Solutions at Becton Dickinson AG.
Ms. Nibauer completed her undergraduate degree at Lehigh University and earned an MBA from UCLA Anderson School of Management.
Anciens postes connus de Lisa Nibauer
Sociétés | Poste | Fin |
---|---|---|
ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | 11/11/2022 |
Becton Dickinson AG
Becton Dickinson AG Medical DistributorsDistribution Services Becton Dickinson AG engages in the development, manufacture, and distribution of single-use medical devices, equipment, antibodies, reagents, and diagnostics. It operates through the following segments: BD Medical, BD Diagnostics, and BD Biosciences. The BD Medical segment manufactures single-use medical devices such as syringes and cannulas. The BD Diagnostics segment specializes in the safe collection and transport of diagnostic samples and offers devices and reagents for the accurate diagnosis of infectious diseases, nosocomial infections, and cancer. The BD Biosciences segments provides solutions to bioscientists, clinical researchers, and physicians working in the areas of basic and drug discovery, vaccine development, biopharmaceutical production, and structured treatment programs. The company was founded on October 27, 1972 and is headquartered in Allschwil, Switzerland. | Corporate Officer/Principal | - |
Formation de Lisa Nibauer
Lehigh University | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORASURE TECHNOLOGIES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Becton Dickinson AG
Becton Dickinson AG Medical DistributorsDistribution Services Becton Dickinson AG engages in the development, manufacture, and distribution of single-use medical devices, equipment, antibodies, reagents, and diagnostics. It operates through the following segments: BD Medical, BD Diagnostics, and BD Biosciences. The BD Medical segment manufactures single-use medical devices such as syringes and cannulas. The BD Diagnostics segment specializes in the safe collection and transport of diagnostic samples and offers devices and reagents for the accurate diagnosis of infectious diseases, nosocomial infections, and cancer. The BD Biosciences segments provides solutions to bioscientists, clinical researchers, and physicians working in the areas of basic and drug discovery, vaccine development, biopharmaceutical production, and structured treatment programs. The company was founded on October 27, 1972 and is headquartered in Allschwil, Switzerland. | Distribution Services |